USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
15 Sep 2021 | 02:45 PM GMT

Masterclass: Clinical Trials Design for Digital Health products

Anchored by:

Vandana Menon
VP, Value, Evidence & Strategy
ALNYLAM PHARMACEUTICALS

Participants:

Vandana Menon VP, Value, Evidence & StrategyAlnylam Pharmaceuticals
Vandana Menon
VP, Value, Evidence & StrategyAlnylam Pharmaceuticals
BB
Brinda Banerjee Sr Director, Digi Medicine, Medical AffairsGenmab
BB
Brinda Banerjee
Sr Director, Digi Medicine, Medical AffairsGenmab
George Platings Director of Business DevelopmentuMotif
George Platings
Director of Business DevelopmentuMotif
Larry Brooks Partner Development ManagerAWS
Larry Brooks
Partner Development ManagerAWS
Laura Farmer Medical Director, ImmunoDerm & RheumatologyJohnson & Johnson
Laura Farmer
Medical Director, ImmunoDerm & RheumatologyJohnson & Johnson
Laura Farmer PresidentOpus Strategy
Laura Farmer
PresidentOpus Strategy
Mansa Shroff Director of Business Dev & Chief of StaffWKD.SMRT
Mansa Shroff
Director of Business Dev & Chief of StaffWKD.SMRT
Mansa Shroff Director, Business Dev. & Chief of StaffWKD.SMRT
Mansa Shroff
Director, Business Dev. & Chief of StaffWKD.SMRT
Meredith Cohen Planning and Projects DirectorPharmStars
Meredith Cohen
Planning and Projects DirectorPharmStars
Vasyl Pyrozhyk Vice PresidentSMBC
Vasyl Pyrozhyk
Vice PresidentSMBC

About this Meeting

There is a broad variety of digital health solutions, but in order to thrive and be successfully adopted, prescribed and reimbursed, it is essential to clinically prove their efficacy and safety. How to design trials for digital health tools so that they are rigorously validated and regulated? Join us in this Masterclass led by Akili Interactive to learn more about:  

  •  Study design and control arm: what types of studies can you use for digital health products? How to select the right comparators?  
  •  Study participants and recruitment: inclusion/exclusion criteria, sample size, socio-demographic groups, recruitment strategies, operational strategies, etc. 
  •  Outcomes and endpoints
  •  How to approach the iterative nature of digital health products? Role of RWE and RWD?